DE3687448D1 - Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten. - Google Patents

Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten.

Info

Publication number
DE3687448D1
DE3687448D1 DE8686115051T DE3687448T DE3687448D1 DE 3687448 D1 DE3687448 D1 DE 3687448D1 DE 8686115051 T DE8686115051 T DE 8686115051T DE 3687448 T DE3687448 T DE 3687448T DE 3687448 D1 DE3687448 D1 DE 3687448D1
Authority
DE
Germany
Prior art keywords
hypoglykaemic
dihydrothiapyrano
pyrimidines
fat
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686115051T
Other languages
English (en)
Other versions
DE3687448T2 (de
Inventor
Richard Saperstein
Richard L Tolman
Eve E Slater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE3687448D1 publication Critical patent/DE3687448D1/de
Application granted granted Critical
Publication of DE3687448T2 publication Critical patent/DE3687448T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE8686115051T 1985-11-04 1986-10-29 Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten. Expired - Fee Related DE3687448T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79488985A 1985-11-04 1985-11-04

Publications (2)

Publication Number Publication Date
DE3687448D1 true DE3687448D1 (de) 1993-02-18
DE3687448T2 DE3687448T2 (de) 1993-06-09

Family

ID=25164002

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686115051T Expired - Fee Related DE3687448T2 (de) 1985-11-04 1986-10-29 Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten.

Country Status (3)

Country Link
EP (1) EP0224722B1 (de)
JP (1) JPS62108816A (de)
DE (1) DE3687448T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898867A (en) * 1987-09-16 1990-02-06 Taiho Pharmaceutical Company, Limited Thienopyrimidine derivaties as aldose-reductase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT278835B (de) * 1967-12-01 1970-02-10 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 7,8-Dihydro-6H-thiopyrano[3,2-d]pyrimidin-5-oxyden und ihren Salzen
NL8300656A (nl) * 1982-02-25 1983-09-16 Maruko Pharmaceutical Co Thiopyranopyrimidineverbindingen en zuuradditiezouten daarvan.

Also Published As

Publication number Publication date
JPS62108816A (ja) 1987-05-20
EP0224722A2 (de) 1987-06-10
EP0224722B1 (de) 1993-01-07
EP0224722A3 (en) 1990-05-30
DE3687448T2 (de) 1993-06-09

Similar Documents

Publication Publication Date Title
DE3583392D1 (de) Carbonatapatit enthaltendes mittel und die verwendung von carbonatapatit fuer implantate.
DE3885049T2 (de) Zubereitung zur Hautpflege.
NL190832C (nl) Tandbehandelingsmiddel met anti-tandsteenwerking.
DE3884021T2 (de) Äusserliches Hautpflegepräparat.
FI872756A0 (fi) Med laserstraolning fungerande terapeutisk anordning.
DE3582894D1 (de) Hautbehandlungsmittel.
NO881113L (no) Hudpleiepreparater.
DE68909970T2 (de) Hautbehandlungsmittel.
DE3789316D1 (de) Herstellung von human-parathyroidhormon.
DE3680838D1 (de) Stabilisierte menschliche prourokinase.
DE3682882D1 (de) Menschliches immunoglobulin-g-fc-region-protein und dessen herstellung.
EP0215956A4 (de) Mittel zur behandlung von hautkrankheiten.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DE3781667D1 (de) Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns.
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
DE3687448D1 (de) Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten.
DE3785804D1 (de) Komforme biomedizinische flachelektrode.
IT8619206A0 (it) Procedimento per la preparazione di 4,4-dialchil-2-azetidinoni.
ATA188385A (de) Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
FI861093A0 (fi) Bioelektrisk patientmonitor.
IT8522356A0 (it) Processo per la preparazione di alfa aloalchil-aril-chetoni otticamente attivi.
DE69002139D1 (de) Kosmetische verwendung von 3-indolbrenztraubensaeure.
DE68902792D1 (de) Mittel zur kosmetischen oder pharmazeutischen verwendung.
ATE49964T1 (de) Benzodioxepane, verfahren zur herstellung und verwendung als heilmittel.
IT1209508B (it) Nuovi medicinali per il trattamento di malattie cardiache.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee